The addition of evolocumab vs ezetimibe to statin therapy for coronary plaque regression and sd-LDL reduction in patients with ultrahigh-risk ASCVD

Journal of Clinical Lipidology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles